FindTrial
Sign In

A BRIEF MOTIVATIONAL INTERVENTION FOR CANNABIS USE DISORDER

ASSESSING THE EFFICACY OF A BRIEF MOTIVATIONAL INTERVENTION FOR CANNABIS USE DISORDER - BMIC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081434
Enrollment
144
Registered
2025-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: ASSESSING THE EFFICACY OF A BRIEF MOTIVATIONAL INTERVENTION FOR CANNABIS USE DISORDER: Brief Motivational Intervention for Cannabis Cessation (BMIC) and Treatment as Usual (TAU) Control

Sponsors

Kalinga Institute of Medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants will be recruited from the inpatient and outpatient departments of KIMS, as well as from residential treatment facilities for substance abuse and cannabis. Participants will range in age from 18 to 60 years old. Patients meeting the DSM-5 criteria for moderate to severe cannabis use disorder,the possibility of having co-morbid substance use disorders, and expressing a willingness to participate and remaining accessible for follow-up assessments are all requirements for participants to be eligible for the study.

Exclusion criteria

Exclusion criteria: Severe mental disorders, organic brain pathology, intellectual disability. Comorbid psychiatric disorders before substance use shall be excluded

Design outcomes

Primary

MeasureTime frame
2. Cannabis Problems Questionnaires -- quantifies negative social, occupational, physical and legal consequences of cannabis use across 16 itemsTimepoint: Cannabis Problems Questionnaires -- quantifies negative social, occupational, physical and legal consequences of cannabis use across 16 itemss Drug Toxicology report shall be added for abstinence markers.—

Secondary

MeasureTime frame
Changes in cannabis-related problems, intensity of cannabis craving, withdrawal symptoms, depression, anxiety, stress levels, and perceived social supportTimepoint: at baseline (before the intervention begins), at 4 weeks (mid-intervention), and at 8 weeks (post-intervention). These assessments capture changes over the course of treatment in areas such as cannabis-related problems, craving intensity, withdrawal symptoms, levels of depression, anxiety, stress (via DASS-21), and perceived social support (via MSPSS), as well as abstinence confirmed through urine tests—

Countries

India

Contacts

Public ContactSidharth Mishra

Kalinga Institute of Medical sciences

sudipta.das@kims.ac.in9861161128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026